Heidi Savage is a seasoned professional with extensive experience in companion diagnostics and oncology biomarker development at Genentech since December 2005. Serving as the Principal Companion Diagnostics Development Leader, Savage has led co-development strategies and supported clinical trials targeting HER2+ breast, multiple myeloma, non-small cell lung, and prostate cancers. Expertise includes IVDR package preparation for clinical trial enrollment in the European Economic Area and a strong background in predictive biomarker identification. Prior roles encompass project leadership and research positions that demonstrate comprehensive skills in biomarker analysis, clinical operations, and molecular diagnostics. Educational credentials include a Bachelor of Arts in Integrative Biology from the University of California, Berkeley, and an Associate of Science from Ohlone College.
This person is not in any teams
This person is not in any offices